Development and Validation of a Propionate Metabolism-Related Gene Signature for Prognostic Prediction of Hepatocellular Carcinoma
Journal of Hepatocellular Carcinoma · 2023-10 · Volume 10 · 1673-1687
DOI: 10.2147/jhc.s420614 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Hepatocellular Carcinoma, 2023-10. Verfasst von Jincheng Xiao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Zhengzhou University Affiliated Cancer Hospital, Zhengzhou, 450008, People's Republic of China. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Background
Studies have demonstrated that propionate metabolism-related genes (PMRGs) are associated with cancer progression. PMRGs are not known to be involved in Hepatocellular carcinoma (HCC).
Methods
In this study, The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases were accessed for HCC-related transcriptome data and clinical information. First, DE-PMRGs were derived by intersecting PMRGs and DEGs between HCC tissues and normal controls. The clusterProfiler R package was then used to enrich DE-PMRGs. In addition, biomarkers of HCC were identified, and a prognostic model was developed. Using functional analysis and tumor microenvironment analysis, new insights were obtained into HCC. The expression of biomarkers was validated using quantitative real-time polymerase chain reaction (qRT-PCR).
Results
132 DE-PMRGs were obtained by intersecting 3690 DEGs and 291 PMRGs. Steroid and organic acid metabolism were associated with these genes. For the construction of the risk model for HCC samples, five biomarkers were identified, including Acyl-CoA dehydrogenase short chain (ACADS), CYP19A1, formiminotransferase cyclodeaminase (FTCD), glucose-6-phosphate dehydrogenase (G6PD), and glutamic-oxaloacetic transaminase (GOT2). ACADS, FTCD, and GOT2 were positive factors, whereas CYP19A1 and G6PD were negative. HCC patients with AUC greater than 0.6 were predicted to survive 1/2/3/4/5 years, indicating decent efficiency of the model. The probability of 1/3/5-survival for HCC was also predicted by the nomogram using the risk score, pathologic T stage, and cancer status. Moreover, functional enrichment analysis revealed the high-risk genes were associated with invasion and epithelial-mesenchymal transition. Significantly, immune cell infiltration and immune checkpoint expression were linked to HCC development.
Conclusion
This study identified five biomarkers of propionate metabolism that can predict HCC prognosis. This finding may provide a deeper understanding of PMRG function in HCC.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, Zhengzhou University Affiliated Cancer Hospital, Zhengzhou, 450008, People's Republic of China.
- Department of General Medicine, the First Medical Center, Department of Chinese PLA General Hospital, Beijing, People's Republic of China.
- Department of Pathology, Huaihe Hospital, Henan University, Henan University, Kaifeng, 475000, People's Republic of China.
- Translational Medical Center of Huaihe Hospital, Henan University, Kaifeng, 475000, People's Republic of China.
- Academy for Advanced Interdisciplinary Studies, Henan University, Zhengzhou, 450046, People's Republic of China.
ORCID-Profile: Junpeng Luo
Zitieren
APA
Xiao, J., Wang, J., Zhou, C., & Luo, J. (2023). Development and Validation of a Propionate Metabolism-Related Gene Signature for Prognostic Prediction of Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma, Volume 10, 1673-1687. https://doi.org/10.2147/jhc.s420614
Vancouver
Xiao J, Wang J, Zhou C, Luo J. Development and Validation of a Propionate Metabolism-Related Gene Signature for Prognostic Prediction of Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma. 2023;Volume 10:1673-1687. doi:10.2147/jhc.s420614
BibTeX
@article{Xiao2023,
author = {Xiao, Jincheng and Wang, Jing and Zhou, Chaoqun and Luo, Junpeng},
title = {Development and Validation of a Propionate Metabolism-Related Gene Signature for Prognostic Prediction of Hepatocellular Carcinoma},
journal = {Journal of Hepatocellular Carcinoma},
year = {2023},
volume = {Volume 10},
pages = {1673--1687},
doi = {10.2147/jhc.s420614}
}
EUVIMED